TMDX (TMDX)
Quantitative Summary
DeterministicFinancial health metrics are strong: Piotroski 7/9, Altman Z 5.0 (above 3.0 safe zone threshold). Beneish M-Score of -0.76 exceeds the -2.22 academic threshold — earnings quality may warrant further review.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics reveal a distinct tension between high-quality earnings generation and capital allocation efficiency. While the company demonstrates robust profitability drivers with net margins at 31.4% and gross margins near 60%, suggesting strong pricing power or cost control, this operational leverage is being eroded by a negative ROIC-WACC spread of -6.1%. This indicates that current returns on invested capital fall short of the required hurdle rate, implying potential value destruction despite impressive revenue growth of 37.1% YoY. Qualitative risk metrics present a mixed picture; a Piotroski F-Score of 7/9 signals strong financial health and improving fundamentals, whereas an Altman Z-Score of 5.0 places the firm in safe territory regarding bankruptcy risk, yet the negative spread suggests management may be deploying capital into lower-yielding opportunities or facing significant reinvestment burdens that dilute shareholder value creation.
Valuation metrics reflect a market premium for growth that appears disconnected from current cash flow generation capabilities relative to cost of equity. Trading at 22.5x earnings is notably elevated compared to typical mature sectors, as the high P/E multiple implicitly assumes sustained acceleration in profitability or margin expansion that must outpace the WACC to justify the price. However, a DCF-based fair value estimate of $33 suggests the current market pricing may be aggressive if it fails to account for the drag imposed by the negative ROIC-WACC spread. The disparity between the high multiple and the cash flow reality implies the stock is priced on future growth expectations rather than present economic returns; any deviation from the projected 37% revenue trajectory or a failure to improve capital efficiency could trigger a significant re-rating downward, as the current valuation does not appear supported by existing operational performance.
Risk assessment highlights a divergence between solvency and value creation potential. Although the Beneish M-Score of -0.76 indicates low probability of earnings manipulation and the Altman Z-Score confirms stability against insolvency, the persistent negative spread acts as a structural headwind that limits total shareholder return regardless of top-line momentum. The data suggests an asymmetric risk profile where downside protection is supported by strong balance sheet metrics, yet upside potential remains constrained until capital allocation strategies shift to generate returns exceeding the 15.9% cost of equity. Investors must weigh whether the current valuation premium adequately compensates for the gap between revenue velocity and actual economic value creation.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 13.9% | 15.9% | 17.9% |
|---|---|---|---|
| 2% | $37 | $32 | $28 |
| 3% | $40 | $33 | $29 |
| 4% | $42 | $35 | $30 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=15.9%, terminal growth 3%. Fair value $33 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
Balance Sheet Health
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like XHE or SLYG, the fund manager is mechanically forced to buy or sell TMDX shares regardless of TMDX's individual fundamentals. We estimate $96M of passive capital is structurally linked to TMDX through 7 tracked ETFs. Passive flows have a limited but growing influence on TMDX's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 7 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in TMDX to visualize passive redemption contagion across ETFs and collateral stocks.
If TMDX (TMDX) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies GLAUKOS CORP (GKOS) as the most exposed collateral stock, sharing 3 ETFs with TMDX. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 7 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
TMDX Ownership Dynamics
ETFs with Highest TMDX Exposure
Float lock-up computed from 8 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
TMDX Capital Efficiency
How efficiently does TMDX convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
TMDX converts 90% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. However, the ROIC-WACC spread is negative (-6.1%), suggesting reinvested capital is destroying shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-07 | 18,854 | $72.92 | $1.4M |
| 2026-05-06 | 2,216 | $94.93 | $210,364.88 |
| 2026-04-30 | 2,111 | $98.57 | $208,081.27 |
| 2026-04-22 | 1,008 | $108.91 | $109,781.28 |
| 2026-04-20 | 94 | $115.87 | $10,891.78 |
| 2026-04-09 | 194 | $109.36 | $21,215.84 |
| 2026-04-06 | 975 | $100.70 | $98,182.5 |
| 2026-04-02 | 339 | $100.40 | $34,035.6 |
| 2026-03-31 | 6,978 | $94.31 | $658,095.18 |
| 2026-03-27 | 47 | $102.20 | $4,803.4 |
| 2026-03-23 | 113 | $113.90 | $12,870.7 |
| 2026-03-19 | 875 | $113.21 | $99,058.75 |
| 2026-03-18 | 650 | $124.72 | $81,068 |
| 2026-03-17 | 755 | $124.70 | $94,148.5 |
| 2026-03-16 | 477 | $123.48 | $58,899.96 |
| 2026-03-09 | 99,526 | $129.61 | $12.9M |
| 2026-03-06 | 320 | $140.07 | $44,822.4 |
| 2026-03-04 | 6,211 | $148.00 | $919,228 |
| 2026-03-03 | 2,052 | $147.00 | $301,644 |
| 2026-02-24 | 25,126 | $134.65 | $3.4M |
| 2026-02-23 | 44,247 | $134.25 | $5.9M |
| 2026-02-20 | 2,302 | $132.88 | $305,889.76 |
| 2026-02-17 | 22,297 | $129.84 | $2.9M |
| 2026-02-13 | 26,340 | $128.52 | $3.4M |
| 2026-02-12 | 86 | $133.30 | $11,463.8 |
| 2026-02-11 | 45,042 | $139.29 | $6.3M |
| 2026-02-10 | 3,960 | $136.34 | $539,906.4 |
| 2026-02-09 | 5,193 | $135.06 | $701,366.58 |
| 2026-02-04 | 149 | $135.72 | $20,222.28 |
| 2026-01-30 | 2,931 | $138.97 | $407,321.07 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare TMDX to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.